Reckitt Benckiser Group plc (LON:RKT – Get Free Report) shares rose 2.2% during mid-day trading on Friday . The company traded as high as GBX 4,868 ($61.03) and last traded at GBX 4,847 ($60.76). Approximately 1,886,302 shares traded hands during mid-day trading, a decline of 41% from the average daily volume of 3,203,260 shares. The stock had previously closed at GBX 4,741 ($59.43).
Wall Street Analyst Weigh In
A number of analysts have commented on RKT shares. JPMorgan Chase & Co. downgraded shares of Reckitt Benckiser Group to a “neutral” rating in a research report on Friday, August 30th. Berenberg Bank lowered their price objective on shares of Reckitt Benckiser Group from GBX 5,200 ($65.19) to GBX 5,177 ($64.90) and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Finally, Jefferies Financial Group restated a “hold” rating and issued a GBX 4,400 ($55.16) target price on shares of Reckitt Benckiser Group in a research report on Monday, July 29th.
View Our Latest Report on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Up 2.2 %
Insider Buying and Selling
In related news, insider Fiona Dawson bought 25 shares of the firm’s stock in a transaction that occurred on Wednesday, October 23rd. The shares were acquired at an average cost of GBX 4,923 ($61.71) per share, for a total transaction of £1,230.75 ($1,542.87). Insiders own 0.05% of the company’s stock.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Disney’s Magic Strategy: Reinventing the House of Mouse
- CD Calculator: Certificate of Deposit Calculator
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.